• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的脂质组学观点。

A lipidomic view of SARS-CoV-2.

机构信息

Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, U.K.

出版信息

Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20210953.

DOI:10.1042/BSR20210953
PMID:34313294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8350433/
Abstract

The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic approaches. New data suggest that lipid metabolism may play a significant role in regulating the response of immune cells like macrophages to viral infection, thereby affecting the outcome of the disease. Therefore, understanding the role of lipid metabolism could help develop new therapeutic approaches to mitigate the social and economic cost of coronavirus disease 2019 (COVID-19).

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的全球大流行始于 2019 年末,已造成巨大的社会和经济损失。越来越多的研究人员专注于了解 SARS-CoV-2 与宿主细胞过程的相互作用,以寻找治疗方法。新数据表明,脂代谢可能在调节巨噬细胞等免疫细胞对病毒感染的反应方面发挥重要作用,从而影响疾病的结果。因此,了解脂代谢的作用可能有助于开发新的治疗方法,以减轻 2019 年冠状病毒病(COVID-19)的社会和经济成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/f64b8a542ba2/bsr-41-bsr20210953-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/669fd3076ba0/bsr-41-bsr20210953-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/2d058232e222/bsr-41-bsr20210953-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/f64b8a542ba2/bsr-41-bsr20210953-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/669fd3076ba0/bsr-41-bsr20210953-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/2d058232e222/bsr-41-bsr20210953-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53dc/8350433/f64b8a542ba2/bsr-41-bsr20210953-g3.jpg

相似文献

1
A lipidomic view of SARS-CoV-2.SARS-CoV-2 的脂质组学观点。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20210953.
2
Dissecting lipid metabolism alterations in SARS-CoV-2.解析 SARS-CoV-2 中的脂质代谢改变。
Prog Lipid Res. 2021 Apr;82:101092. doi: 10.1016/j.plipres.2021.101092. Epub 2021 Feb 8.
3
Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows.代谢组学能否左右 COVID-19 大流行的命运?一篇关于光明与黑暗的叙述性综述。
Clin Chem Lab Med. 2021 Jul 30;59(12):1891-1905. doi: 10.1515/cclm-2021-0414. Print 2021 Nov 25.
4
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎:分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
5
The Pathogenic Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Possible Mechanisms for Immune Evasion?严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)的致病特征:免疫逃避的可能机制?
Front Immunol. 2021 Jul 14;12:693579. doi: 10.3389/fimmu.2021.693579. eCollection 2021.
6
Multiomics integration-based molecular characterizations of COVID-19.基于多组学整合的 COVID-19 分子特征分析。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab485.
7
Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.对 COVID-19 病理生理学、免疫发病机制、检测和治疗的分子洞察。
DNA Cell Biol. 2021 Jul;40(7):858-868. doi: 10.1089/dna.2021.0068. Epub 2021 May 14.
8
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target.脂代谢在 COVID-19 病毒感染中的作用及其作为药物靶点的研究。
Int J Mol Sci. 2020 May 17;21(10):3544. doi: 10.3390/ijms21103544.
9
SARS-CoV-2-specific virulence factors in COVID-19.COVID-19 中的 SARS-CoV-2 特异性毒力因子。
J Med Virol. 2021 Mar;93(3):1343-1350. doi: 10.1002/jmv.26615. Epub 2020 Nov 1.
10
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.细胞因子风暴:COVID-19 恶化的病理生理演变的主要决定因素。
Front Immunol. 2021 Apr 28;12:589095. doi: 10.3389/fimmu.2021.589095. eCollection 2021.

引用本文的文献

1
Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19.早期代谢组学和免疫学生物标志物作为COVID-19的预后指标
Metabolites. 2024 Jul 9;14(7):380. doi: 10.3390/metabo14070380.
2
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.精准营养以重置长期新冠病毒感染中病毒诱导的人类代谢重编程和失调(HMRD)。
NPJ Sci Food. 2024 Mar 30;8(1):19. doi: 10.1038/s41538-024-00261-2.
3
Superoxide dismutase alterations in COVID-19: implications for disease severity and mortality prediction in the context of omicron variant infection.

本文引用的文献

1
Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2.隐匿于众目睽睽之下:共生微生物群的天然产物作为新冠病毒新变种出现的环境选择压力
Chembiochem. 2021 Oct 13;22(20):2946-2950. doi: 10.1002/cbic.202100346. Epub 2021 Jul 26.
2
Lipid metabolism changes in patients with severe COVID-19.严重 COVID-19 患者的脂代谢变化。
Clin Chim Acta. 2021 Jun;517:66-73. doi: 10.1016/j.cca.2021.02.011. Epub 2021 Feb 24.
3
Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry.
新冠病毒感染(COVID-19)中超氧化物歧化酶的改变:在奥密克戎变异株感染背景下对疾病严重程度和死亡率预测的意义
Front Immunol. 2024 Feb 22;15:1362102. doi: 10.3389/fimmu.2024.1362102. eCollection 2024.
4
Unraveling lipid and inflammation interplay in cancer, aging and infection for novel theranostic approaches.解析脂质与炎症在癌症、衰老和感染中的相互作用,探索新的治疗策略。
Front Immunol. 2024 Feb 1;15:1320779. doi: 10.3389/fimmu.2024.1320779. eCollection 2024.
5
Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19.非靶向血浆代谢组学指纹图谱揭示了几种用于冠状病毒病19诊断和预后的生物标志物。
Front Med (Lausanne). 2022 Sep 29;9:995069. doi: 10.3389/fmed.2022.995069. eCollection 2022.
6
COVID-19 metabolism: Mechanisms and therapeutic targets.新型冠状病毒肺炎的代谢:机制与治疗靶点。
MedComm (2020). 2022 Aug 9;3(3):e157. doi: 10.1002/mco2.157. eCollection 2022 Sep.
7
Enzymes in the time of COVID-19: An overview about the effects in the human body, enzyme market, and perspectives for new drugs.新冠疫情期间的酶:对人体影响、酶市场及新药前景的概述。
Med Res Rev. 2022 Nov;42(6):2126-2167. doi: 10.1002/med.21919. Epub 2022 Jun 28.
8
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy).非靶向脂质组学揭示了来自意大利坎帕尼亚地区不同严重程度 COVID-19 患者的特定脂质特征。
J Pharm Biomed Anal. 2022 Aug 5;217:114827. doi: 10.1016/j.jpba.2022.114827. Epub 2022 May 10.
采用超高效液相色谱-高分辨质谱法研究康复期 COVID-19 患者血浆中的脂质组学改变。
Biosci Rep. 2021 Mar 26;41(3). doi: 10.1042/BSR20204305.
4
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19.COVID-19 患者的脂质代谢失调和病理性炎症。
Sci Rep. 2021 Feb 3;11(1):2941. doi: 10.1038/s41598-021-82426-7.
5
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.糖尿病、肥胖症、新陈代谢与新型冠状病毒感染:开端的结束。
Cell Metab. 2021 Mar 2;33(3):479-498. doi: 10.1016/j.cmet.2021.01.016. Epub 2021 Jan 21.
6
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.前沿:人类严重的 SARS-CoV-2 感染由血清脂质组的变化定义,导致花生四烯酸免疫介质的失调。
J Immunol. 2021 Jan 15;206(2):329-334. doi: 10.4049/jimmunol.2001025. Epub 2020 Dec 4.
7
Interferon-stimulated gene products as regulators of central carbon metabolism.干扰素刺激基因产物作为中心碳代谢的调节剂。
FEBS J. 2021 Jun;288(12):3715-3726. doi: 10.1111/febs.15625. Epub 2020 Dec 1.
8
ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?单链RNA病毒与宿主脂质重排:脂滴在新型冠状病毒感染中起作用吗?
Front Mol Biosci. 2020 Oct 8;7:578964. doi: 10.3389/fmolb.2020.578964. eCollection 2020.
9
Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries.新冠大流行第一波对 21 个工业化国家全因死亡率影响的规模、人口统计学特征和动态。
Nat Med. 2020 Dec;26(12):1919-1928. doi: 10.1038/s41591-020-1112-0. Epub 2020 Oct 14.
10
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.COVID-19 激活的 SREBP2 扰乱胆固醇生物合成并导致细胞因子风暴。
Signal Transduct Target Ther. 2020 Sep 3;5(1):186. doi: 10.1038/s41392-020-00292-7.